Moderators of fluoxetine treatment response for children and adolescents with comorbid depression and substance use disorders

Our recent 8-week, randomized, placebo-controlled trial of fluoxetine in adolescents (ages 12–17 years) with comorbid depression and substance use disorder (SUD) did not detect a significant antidepressant treatment effect. The purpose of this secondary analysis was to explore moderators of the effe...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Hirschtritt, Matthew E., Pagano, Maria E., Christian, Kelly M., McNamara, Nora K., Stansbrey, Robert J., Lingler, Jacqui, Faber, Jon E., Demeter, Christine A., Bedoya, Denise, Findling, Robert L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2011
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3415216/
https://ncbi.nlm.nih.gov/pubmed/22116008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsat.2011.09.010
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller